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In Utero and Early-Life Conditions and Adult Health  
and Disease
To the Editor: In their article on the develop-
mental origin of disease, Gluckman et al. (July 3 
issue)1 state that “an altered long-term risk of 
disease is initially induced through adaptive re-
sponses that the fetus or infant makes to cues 
from the mother about her health or physical state.” 
This rather narrow definition and the overall fo-
cus of the review leave out adverse responses due 
to maternal exposures to environmental chemi-
cals, occupational hazards, drugs, tobacco smok-
ing, or infection. These factors are likely to make 
a very large contribution to adult diseases of de-
velopmental origin, and they have the advantage 
of being potentially preventable.2 Risk assessment 
of environmental hazards must therefore include 
the effects of developmental exposures to stimu-
late better protection of the most vulnerable life 
stages.
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To the Editor: The article by Gluckman et al. 
highlights an ongoing fundamental change in 
medical thinking known as the life-course ap-
proach to the development of disease. The “devel-
opmental model” of chronic diseases postulates 
that early-life events affect individual differences 
in vulnerability to lifestyle and environment. This 
concept is supported by studies of in utero or at-
birth conditions on future diseases by the fact that 
differences in adult lifestyles only partially explain 
the development of diseases.1
Considering the aging of the worldwide pop-
ulation and the associated increase in the preva-
lence of chronic diseases, research on the ini-
tiating events of such diseases is valuable and 
necessary, but research on possible synergism or 
antagonism between in utero and childhood or 
adulthood conditions on elderly health could be 
as important for future public health policies. For 
example, the interaction between education — 
which has been found to be inversely associated 
with both multiple chronic conditions2 and Alz-
heimer’s disease3 in the elderly population — and 
in utero environment might be a pioneering proj-
ect in this growing research field.
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To the Editor: Gluckman et al. review evidence 
on the effects of fetal conditions on adult disease. 
However, an important potential player is being 
left out of their discussion. Prenatal inflamma-
tion, reflected by chorioamnionitis and the fetal 
inflammatory response syndrome, has been rec-
ognized as a fetal condition that contributes to dis-
ease in the perinatal period and beyond, mainly 
affecting the developing lung and brain.1,2 The 
evidence is increasing that prenatal exposure to 
inflammation in utero is related to disease, later 
in childhood, involving the affected organs and 
is associated with physician-diagnosed asthma,3 
recurrent wheezing,3 autistic behavior,4 and adverse 
neurodevelopmental outcome.5 Experimental cho-
rioamnionitis results in pathogenic programming 
of the fetal immune response, endotoxin tolerance, 
and crucial developmental changes, suggesting an 
important programming effect.1 Thus, accumu-
lating evidence implies an important role of an-
tenatal inflammation in fetal programming and 
subsequent disease development, the mechanisms 
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of which need further investigation. Considering 
the immature stage of the exploration of these 
effects, we may well currently be looking at the 
tip of the iceberg, anticipating potential links with 
adult pulmonary and neurologic diseases like 
chronic obstructive pulmonary disease and de-
mentia.
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The authors reply: We are pleased with the in-
terest in our review, particularly, as noted, con-
cerning the relevance of developmental exposures 
(environmental toxins, smoking, and alcohol con-
sumption), intermediary phenotypes (chronic low-
grade inflammation), and health outcomes (aging 
and cognitive decline). Although we focused on 
metabolic, cardiovascular, and bone disease, the 
areas most developed, we have little doubt that 
developmental plasticity and epigenetic change 
have much greater involvement in the etiology of 
human disease than has previously been consid-
ered. We would urge further research to clarify 
the involved epigenetic mechanisms, to develop 
risk-prediction tools that might be applied through-
out the life course, and to delineate preventive and 
interventional strategies.
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A Case of Conjugal Azathioprine-Induced Contact Hypersensitivity
To the Editor: A man in his early 30s presented 
with an intermittent eczematous eruption over the 
shaft of his penis and scrotum (Fig. 1A). His wife 
was initially concerned about his fidelity, but a 
careful history-taking revealed that the rash coin-
cided with his wife’s intermittent courses of aza-
thioprine for Crohn’s disease. During four courses 
of such treatment over a 4-year period, her vaginal 
secretions were yellow, which raised the possibil-
ity of secretion of azathioprine or its metabolites 
that could have led to allergic contact dermatitis 
in the husband.
Further investigation was undertaken. Both 
the man and his wife had normal thiopurine 
methyl transferase levels. Epicutaneous patch test-
ing of petrolatum alone or 1 to 10% of the drug 
in petrolatum was performed as previously de-
scribed.1 Azathioprine (pure and tablet forms), its 
major breakdown product 6-mercaptopurine, and 
all available tablet excipients were tested on both 
partners. The husband, but not the wife, reacted 
to the tablet and pure forms of azathioprine only 
(Fig. 1B).
The presence of drug-specific lymphocytes in 
the husband’s peripheral-blood mononuclear cells 
was assessed by means of the lymphocyte trans-
formation test,2 but no response was seen, prob-
ably reflecting the inherent antilymphocyte activ-
ity of azathioprine. However, as shown with the 
use of an enzyme-linked immunosorbent spot 
assay,3 both azathioprine and 6-mercaptopurine 
induced the release of interferon-γ from lympho-
cytes (50 and 70 positive cells per million, respec-
tively, vs. 4 positive cells per million in the absence 
of drug) (Fig. 1C and 1D). No response was seen 
in controls (see the Supplementary Appendix, 
available with the full text of this letter at www.
nejm.org). These data, in conjunction with the 
skin-test results, were interpreted to indicate that 
the husband had a hypersensitivity to 6-mercap-
topurine or a metabolite of 6-mercaptopurine. The 
negative skin test for 6-mercaptopurine probably 
reflected its water solubility, causing it to penetrate 
into the epidermis much less than azathioprine.
Azathioprine is inactive until converted to 
6-mercaptopurine and methyl-nitro-thioimidazole 
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